After then, FEZF1-AS1 was successively found to be up-regulated in kinds of malignancies, like pancreatic cancer (PC), hepatocellular carcinoma (HCC), breast cancer (BC), non-small-cell lung cancer (NSCLC) and gastric cancer (GC) [11–15]. Here, FEZF1 is linked to gastric cancer.